Heart Failure

The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure | October 18, 2017

October 18, 2017 — The U.S. Food and Drug Administration (FDA) recently approved a new treatment option for patients...

First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure | October 17, 2017

October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S. arm of the ALIVE...

Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD) | October 04, 2017

October 4, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) approval for its HeartWare HVAD System...

Abiomed Receives FDA PMA Approval for Impella RP for Right Heart Failure
Technology | Ventricular Assist Devices (VAD) | September 28, 2017

September 28, 2017 — Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA...

Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017

September 27, 2017 — Boston Scientific recently launched the Resonate family of...

BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies | September 26, 2017

September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT...

CardiAMP Heart Failure Trial Design Presented at Texas Heart Institute Symposium
News | Heart Failure | September 25, 2017

September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure...

MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure | September 21, 2017

September 21, 2017 — MyoKardia Inc. announced that additional positive data from the first patient cohort of its...

Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure | September 19, 2017

September 19, 2017 — The heart failure...

Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure | September 06, 2017

September 6, 2017 — Physicians identified a majority of patients with advanced...

Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure | September 05, 2017

September 5, 2017 — Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from...

Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD) | August 29, 2017

August 29, 2017 — Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full...

Videos | Cardiovascular Ultrasound | August 28, 2017

This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is...

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT) | August 21, 2017

August 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability...

BioCardia Completes Roll-in Cohort in Pivotal Phase III CardiAMP Heart Failure Trial
News | Stem Cell Therapies | August 16, 2017

August 16, 2017 — BioCardia Inc. recently announced completion of treatment for the 10-patient roll-in cohort for...

Overlay Init